• This topic is empty.
Viewing 0 reply threads
  • Author
    • #24817
      Kevin Schaefer

      Happy Thursday!

      Check out the latest podcast here. In this episode, Michael and I discuss news regarding the FDA-approved treatment Evrysdi, and Michael’s decision to switch to this therapy. We also talk about the clinical trial drug SRK-015, which is developed by Scholar Rock. Finally, I read excerpts from some of our recent columns. 

      Hope you enjoy listening!

      Do you have any takeaways from this episode? Any questions regarding Evrysdi or SRK-015?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account

Verify you are not a robot